Delivery Order SPE2DB22D3011-SPE2DB25FQ2LD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections with a contract ceiling value of $47,883.19. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by August 7, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,029.53 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The contract carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.90 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections on September 2, 2025, with a completion date of September 3, 2025. This non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, indicating it is issued under a larger indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $10,988.77 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 12, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by June 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,353.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 12, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a single transaction under a larger indefinite delivery vehicle that enables DLA to...
- The Defense Logistics Agency awarded a $5,496.91 delivery order to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 ml pen injections on May 30, 2025, with a completion date of June 2, 2025. This firm fixed price contract is non-set-aside and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at AmerisourceBergen's corporate...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2LDDelivery Order
The Defense Logistics Agency awarded a $5,441.80 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 27, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with DLA and supports critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Mounjaro order reflects the company's role in supplying specialty medications, including diabetes treatments, to support military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/26/25 |